Chaim Lebovits; President, Chief Executive Officer; Brainstorm Cell Therapeutics Inc. Alla Patlis; Interim Chief ...
EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T ...
Sutro Biopharma, Inc.’s STRO share price has dipped by 10.88%, which has investors questioning if this is right time to buy.
A research team has identified a previously unknown degradation mechanism that occurs during the use of lithium-ion batteries ...
A study conducted by Prof. Thai-Yen Ling at National Taiwan University underscores the potential of small extracellular ...
Sale ends today, so act fast to get some of the year's best prices on top-rated TVs from some of our favorite brands like ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical ...
The nuclei in our cells are miniature warehouses safeguarding the genetic blueprint for the body's biologic machinery. As ...
At Microsoft, we’ve worked with leading innovators across industries, helping them not just experiment with AI, but deploy it ...
Discover Nkarta's groundbreaking cell therapy advancements, robust financials, and investment potential. Click here to read ...
17h
Zacks Investment Research on MSNBio-Techne Opens New Customer Experience Centre in GermanyBio-Techne Corporation TECH recently opened a new Customer Experience Centre in Düsseldorf, Germany, to serve customers across the Europe, Middle East and Africa (“EMEA”) region. The facility's ...
AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal investigations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results